已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke

医学 依达拉奉 冲程(发动机) 内科学 混淆 相伴的 缺血性中风 心脏病学 物理疗法 缺血 机械工程 工程类
作者
Susumu Kobayashi,Shingo Fukuma,Tatsuyoshi Ikenoue,Shunichi Fukuhara,Shotai Kobayashi
出处
期刊:Stroke [Ovid Technologies (Wolters Kluwer)]
卷期号:50 (7): 1805-1811 被引量:58
标识
DOI:10.1161/strokeaha.118.024351
摘要

Background and Purpose— In Japan, nearly half of ischemic stroke patients receive edaravone for acute treatment. The purpose of this study was to assess the effect of edaravone on neurological symptoms in patients with ischemic stroke stratified by stroke subtype. Methods— Study subjects were 61 048 patients aged 18 years or older who were hospitalized ≤14 days after onset of an acute ischemic stroke and were registered in the Japan Stroke Data Bank, a hospital-based multicenter stroke registration database, between June 2001 and July 2013. Patients were stratified according to ischemic stroke subtype (large-artery atherosclerosis, cardioembolism, small-vessel occlusion, and cryptogenic/undetermined) and then divided into 2 groups (edaravone-treated and no edaravone). Neurological symptoms were evaluated using the National Institutes of Health Stroke Scale (NIHSS). The primary outcome was changed in neurological symptoms during the hospital stay (ΔNIHSS=NIHSS score at discharge−NIHSS score at admission). Data were analyzed using multivariate linear regression with inverse probability of treatment weighting after adjusting for the following confounding factors: age, gender, and systolic and diastolic blood pressure at the start of treatment, NIHSS score at admission, time from stroke onset to hospital admission, infarct size, comorbidities, concomitant medication, clinical department, history of smoking, alcohol consumption, and history of stroke. Results— After adjusting for potential confounders, the improvement in NIHSS score from admission to discharge was greater in the edaravone-treated group than in the no edaravone group for all ischemic stroke subtypes (mean [95% CI] difference in ΔNIHSS: −0.46 [−0.75 to −0.16] for large-artery atherosclerosis, −0.64 [−1.09 to −0.2] for cardioembolism, and −0.25 [−0.4 to −0.09] for small-vessel occlusion). Conclusions— For any ischemic stroke subtype, edaravone use (compared with no use) was associated with a greater improvement in neurological symptoms, although the difference was small (<1 point NIHSS) and of limited clinical significance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
绝不内耗完成签到,获得积分10
1秒前
潇洒忘幽关注了科研通微信公众号
1秒前
路旁小白完成签到,获得积分10
2秒前
wyz发布了新的文献求助10
2秒前
今后应助健忘的初翠采纳,获得10
3秒前
Lucas应助王军采纳,获得10
5秒前
日天的马铃薯完成签到,获得积分10
6秒前
Hello应助调皮的天真采纳,获得10
8秒前
11秒前
zhou完成签到,获得积分20
12秒前
13秒前
潇洒忘幽发布了新的文献求助10
14秒前
15秒前
15秒前
知行合一完成签到,获得积分10
16秒前
17秒前
17秒前
zqy1111发布了新的文献求助10
18秒前
18秒前
万能图书馆应助记忆缺失采纳,获得30
18秒前
王军发布了新的文献求助10
20秒前
20秒前
ZXC发布了新的文献求助10
20秒前
李健应助个性凡儿采纳,获得10
21秒前
21秒前
orixero应助个性凡儿采纳,获得10
21秒前
打打应助个性凡儿采纳,获得10
21秒前
小二郎应助个性凡儿采纳,获得10
21秒前
uziMOF发布了新的文献求助10
21秒前
烟花应助个性凡儿采纳,获得10
21秒前
乐乐应助个性凡儿采纳,获得10
21秒前
bkagyin应助个性凡儿采纳,获得10
21秒前
852应助个性凡儿采纳,获得10
21秒前
顾矜应助个性凡儿采纳,获得10
22秒前
无花果应助个性凡儿采纳,获得10
22秒前
22秒前
脑洞疼应助科研通管家采纳,获得10
22秒前
李爱国应助科研通管家采纳,获得10
22秒前
不配.应助科研通管家采纳,获得20
22秒前
丘比特应助科研通管家采纳,获得10
22秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 830
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3248513
求助须知:如何正确求助?哪些是违规求助? 2891915
关于积分的说明 8269223
捐赠科研通 2559929
什么是DOI,文献DOI怎么找? 1388807
科研通“疑难数据库(出版商)”最低求助积分说明 650897
邀请新用户注册赠送积分活动 627798